|
0
|
|
NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.
(pnas.org)
|
White MC
…
Damania B
PNAS
2026-05-19
|
#infection
#amr
#virulence
#cancer
|
|
0
|
|
Mtb-Timer: a fluorescent reporter to visualize Mycobacterium tuberculosis replication and antibiotic responses.
(journals.asm.org)
|
Campo-Perez V
…
Gutierrez MG
mSystems
2026-05-19
|
#amr
#single-cell
#fluorescent
#reporter
#tb
|
|
0
|
|
Host genetics shapes the recovery of the gut microbiome after antibiotic treatment: the role of the blood group related B4galnt2 gene.
(journals.asm.org)
|
Cepic A
…
Baines JF
mSystems
2026-05-19
|
#microbiome
#amr
#metagenomics
#dysbiosis
#transcriptomics
|
|
0
|
|
ICMT supports BRAF(V600E)-driven tumor growth by membrane targeting of the CAAX protein INPP5E.
(pnas.org)
|
Yang X
…
Bergo MO
PNAS
2026-05-19
|
#amr
#cancer
#signaling
#melanoma
#mutation
|
|
0
|
|
Human lifestyle-associated factors modulate the gut resistome.
(journals.asm.org)
|
Poopalarajah R
…
Jha AR
mSystems
2026-05-19
|
#microbiome
#amr
#metagenomics
#dysbiosis
|
|
0
|
|
Accelerating scientific discovery with Co-Scientist.
(nature.com)
|
Gottweis J
…
Natarajan V
Nature
2026-05-19
|
#amr
#ai
#drug discovery
#hypothesis
|
|
0
|
|
Overcoming ADC resistance in advanced colorectal cancer by dual targeting of TROP2 and PERK to suppress Wnt/beta-catenin signaling.
(linkinghub.elsevier.com)
|
Liu J
…
Zhang S
Cell Reports Medicine
2026-05-19
|
#amr
#cancer
#signaling
#targeted therapy
#combination therapy
|
|
0
|
|
Metabolic reprogramming of the infant gut by bifidobacteria-based probiotics drives exclusion of antibiotic-resistant pathobionts.
(linkinghub.elsevier.com)
|
Bargheet A
…
Pettersen VK
Cell Reports Medicine
2026-05-19
|
#microbiome
#metabolomics
#amr
#metagenomics
#probiotic
|